Rapid Viral Clone Assembly via Type IIS Enzyme Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for constructing SARS-CoV-2 infectious clones are laborious and time-consuming, limiting the ability to rapidly investigate emerging variants and requiring weeks for assembly, which hampers timely research and public health responses.
Innovation Solution
A method involving the assembly of recombinant viral genomes from partially overlapping DNA segments using Type IIS restriction endonuclease sites, allowing for rapid generation of infectious clones such as SARS-CoV-2, SARS-CoV-2 variants, and other viruses like HKU1 and RSV, without the need for patient isolates, by cloning and ligating these segments into a plasmid, enabling sequence verification and accelerated research.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional methods are used to construct infectious clones, then the assembly process is thorough and reliable, but the time required increases to several weeks
Solution Approach 1:
The viral genome is divided into multiple overlapping DNA segments that can be independently cloned and validated before assembly. This segmentation allows for parallel processing of individual segments, reducing overall construction time while maintaining assembly reliability through systematic recombination of validated pieces
Solution Approach 2:
DNA segments are pre-cloned, pre-validated for sequence accuracy, and pre-prepared with appropriate restriction sites before final assembly. This preliminary preparation ensures that when segments are assembled, the process is both faster and reliable, as each segment has already been quality-checked
2Reliability
If patient isolates are used for virus propagation, then the viral variants are authentic, but the time required to collect and propagate increases to weeks
Solution Approach 1:
Instead of working with physical patient isolates that require collection and propagation, the invention uses synthesized DNA copies of the viral genome based on sequence data. These synthetic copies can be directly assembled and transfected, eliminating the time-consuming isolation and propagation steps while maintaining variant authenticity through sequence verification
Solution Approach 2:
The biological process of virus propagation in cell cultures is replaced with in vitro DNA assembly and transfection methods. This substitution of mechanical/molecular techniques for biological propagation dramatically reduces time while maintaining the ability to study authentic viral variants
3Reliability
If complete viral genomes are assembled, then the infectious clones are functional, but the complexity of the assembly process increases
Solution Approach 1:
The complete viral genome is segmented into manageable overlapping pieces that can be assembled in a standardized, repeatable manner. This segmentation reduces complexity by breaking down the daunting task of assembling entire genomes into routine operations on smaller, standardized fragments
Solution Approach 2:
The invention uses Type IIS restriction enzymes that recognize specific DNA sequences and cut at defined distances from the recognition site, enabling precise control over fragment assembly. This parameter-based control (specific restriction sites, defined overlap lengths) standardizes the assembly process, reducing complexity while ensuring functional results
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly reduces the time to construct infectious clones to 1-2 weeks, producing a clonal population that can be sequence verified, thereby enhancing the speed and quality of research on emerging variants and improving public health responses.
Implementation Method 1
digesting the clones of c) with the Type IIS restriction enzyme, releasing the cloned insert DNA segments
Implementation Method 2
annealing and ligating in a single pot into a destination plasmid
Data Source
AI summary
Provided herein is a novel cloning system with rational fragment design and single-pot ligation (pGLUE) that allows systematic exchange and mutagenesis of genes and rapid construction of entire molecular clones and replicons of virus within days.